Call for Proposals: Collaborative Research and Capacity Building Initiative in HIV and Schistosomiasis is EXTENDED
- Details
- Category: Call for Proposals
One of the strategic objectives of Philippine National Health Research System (PNHRS) for 2019-2022 is to strengthen the capacity of the network to support health research. To address this objective, the PNHRS Capacity Building Committee (CBC) created the Collaborative Research and Capacity Building Initiative which will integrate the capacity building efforts of the implementing agencies, regional consortia, and member institutions. Harmonizing the efforts in research capacity will result in better use of resources which will contribute to the development of evidence-informed health decisions, programs, and policies.
The Collaborative Research and Capacity Building Initiative has the following objectives:
- Promote partnership and collaboration among researchers/research and development institutions in health research capacity building;
- Harmonize R&D capacity building efforts through interregional and interdisciplinary collaborative research;
- Optimize resources for health R&D capacity building programs for researchers and research and development institutions; and
- Develop more relevant and quality health researches aligned with National Unified Health Research Agenda (NUHRA) and Regional Unified Health Research Agenda.
Priority Areas for Funding
For its initial phase, the initiative accepts proposals on control and prevention of human immunodeficiency virus (HIV) and schistosomiasis.
The program must have at least 2-3 of the following research project components: (1) clinical/epidemiology/diagnostics, (2) use of ICT, (3) health social science, and (4) health policy and systems research.
Minimum Requirements for the Proposals
All proposals submitted for funding must comply with the following requirements:
- Must involve the Research and Development Institution’s (RDI) or Higher Education Institutions’ (HEIs) faculty/researcher and early career scientists
- Must include a mechanism for sharing of resources (expertise, data/information, facilities) for research
- Must be collaborative, interregional, and interdisciplinary, involving 2-3 RDIs/HEIs through letter of support or willingness to collaborate
- Must include plans for research dissemination, utilization, and translation
- Duration: 1-2 years (PNHRS implementing agencies and counterpart implementing RDIs/non-RDIs shall provide funding for approved proposals for 1-2 years, subject to monitoring and evaluation and annual review)
Who may submit
Principal investigators must be a Filipino with at least a Master’s Degree in a relevant field and employed in universities/colleges, research agencies/institutes, hospitals, and other health related agencies who are members of the Central Luzon Health Research and Development Consortium (CLHRDC) are eligible to apply for the research grant.
How to submit
Interested lead proponents must submit their capsule proposals using the DOST-PCHRD forms to CLHRDC.
Deadline of submission of capsule proposal to consortium is on or before June 30, 2020.
**Qualified capsule proposals will be endorsed by the CLHRDC concerned to PNHRS CBC secretariat. The successful proponents will be invited to join a write-shop for the development of the full proposal.
For inquiries, you may email This email address is being protected from spambots. You need JavaScript enabled to view it..
2020 CALL FOR APPLICATIONS PhD Program in Molecular Biomedicine
- Details
- Category: Call for Proposals
Overview
The Department of Science and Technology – Philippine Council for Health Research and Development (PCHRD), the University of Trieste (UNITS) and Fondazione Italiana Fegato (FIF) enter into an Agreement to develop and implement of a program focused on molecular hepatology within the PhD Program in Molecular Biomedicine of UNITS. This Fellowship program integrates basic research and clinics focusing on the study of molecular approaches to cancer biology, genetics, jaundice and metabolic diseases. The duration of the program is for 3 years.
Applicant’s research interests must be aligned with the National Unified Health Research Agenda (NUHRA) and National Harmonized Research and Development Agenda.
Objectives
The PhD program aims to achieve the following objectives:
- Develop a pool of high-quality human resources in molecular hepatology in particular who will contribute to the country’s global competitiveness and economic development;
- Provide opportunities to deserving students to study and obtain PhD degrees in Molecular Biomedicine in reputable institutions abroad;
- Contribute to the country’s health research and technological innovation capabilities through training on biomedical research;
- Create the basis for a Filipino Liver Network integrating basic and clinical research in liaison with FIF.
Capacity
Two positions of PhD students will be available each year at UNITS (Subject to the availability of funds)
Eligibility
The applicant must:
- Be a Filipino citizen;
- Be in good health condition;
- Not be more than 40 years old at the time of application;
- Hold a Master's degree in a field relevant to health and biomedicine;
- Have an outstanding academic record;
- Passed the admission requirements for the PhD study;
- Passed the interview and other screening procedures;
- Conduct her/his research for the entire duration of the scholarship and of the PhD Program.
Scholarship Privileges
- Living allowance (20,000€/year);
- Book allowance (500€/year);
- Bench fee (4,000€/year);
- Health and accident insurance; and
- One round-trip economy fare from residence to Italy.
Selection Procedure
|
1st Selection Document Screening |
Documentary evaluation of the form and other requirements by DOST-PCHRD |
|
2nd Selection Technical Interview |
Technical interview by a panel composed of DOST-PCHRD Director, FIF Scientific Director (or a FIF delegate), or a member of the PhD Program in Molecular Biomedicine of the UNITS, and other health research experts to assess: · Academic background and learning ability · Capacity for completing the study · Possibility of contributing to the development of the country · Compatibility to the university course The interview will take place at DOST-PCHRD. |
|
3rd and Final Selection |
A panel from the PhD Program in Molecular Biomedicine (UNITS) will identify the successful PhD student(s) from among the candidates selected in the Technical Interview, based on their academic records and the selection criteria as established by UNITS. |
Timeline
|
March 17 |
Opening of the PCHRD Call for Applications |
|
May 15 |
Application deadline |
|
June - July |
Document Screening, Interview, and Announcement of the selected candidate(s) |
|
August - September |
Preparation of necessary documents (visa, insurance, bank account) |
|
November 1 |
Start of PhD program |
List of Application Documents (Forms) for PCHRD screening
- CV
- Accomplished application form with ID picture
- PSA Birth Certificate
- Valid NBI Clearance
- Endorsement Letter from two (2) former professors in MS program
- Certificate of Employment (if employed, recommendation and permission to take a leave of absence from employer or head of agency while on scholarship)
- Medical Certificate as to health status from a licensed physician with his/her PRC license number indicated
- Certificate of Master Degree
- Admission to Graduate Studies/Graduate School
- Transcript of Records (certified true copy)
- Program of Study/Course Curriculum (if available or to follow)
- Re-entry Plan (narrative)
- Budgetary Requirements (attach at least 3 airfare canvasses and website references for items requested)
Documents must be submitted to:
Address: Saliksik Building, DOST Compound, Gen. Santos Ave., Bicutan Taguig City 1631 Philippines
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
2020 CALL FOR PROPOSALS COLLABORATIVE RESEARCH AND CAPACITY BUILDING INITIATIVE IN HIV AND SCHISTOSOMIASIS
- Details
- Category: Call for Proposals
One of the strategic objectives of Philippine National Health Research System (PNHRS) for 2019-2022 is to strengthen the capacity of the network to support health research. To address this objective, the PNHRS Capacity Building Committee (CBC) created the Collaborative Research and Capacity Building Initiative which will integrate the capacity building efforts of the implementing agencies, regional consortia, and member institutions. Harmonizing the efforts in research capacity will result in better use of resources which will contribute to the development of evidence-informed health decisions, programs, and policies.
The Collaborative Research and Capacity Building Initiative has the following objectives:
- Promote partnership and collaboration among researchers/research and development institutions in health research capacity building;
- Harmonize R&D capacity building efforts through interregional and interdisciplinary collaborative research;
- Optimize resources for health R&D capacity building programs for researchers and research and development institutions; and
- Develop more relevant and quality health researches aligned with National Unified Health Research Agenda (NUHRA) and Regional Unified Health Research Agenda.
Priority Areas for Funding
For its initial phase, the initiative accepts proposals on control and prevention of human immunodeficiency virus (HIV) and schistosomiasis.
The program must have at least 2-3 of the following research project components: (1) clinical/epidemiology/diagnostics, (2) use of ICT, (3) health social science, and (4) health policy and systems research.
Minimum Requirements for the Proposals
All proposals submitted for funding must comply with the following requirements:
- Must involve the Research and Development Institution’s (RDI) or Higher Education Institutions’ (HEIs) faculty/researcher and early career scientists
- Must include a mechanism for sharing of resources (expertise, data/information, facilities) for research
- Must be collaborative, interregional, and interdisciplinary, involving 2-3 RDIs/HEIs through letter of support or willingness to collaborate
- Must include plans for research dissemination, utilization, and translation
- Duration: 1-2 years (PNHRS implementing agencies and counterpart implementing RDIs/non-RDIs shall provide funding for approved proposals for 1-2 years, subject to monitoring and evaluation and annual review)
Who may submit
Principal investigators must be a Filipino with at least a Master’s Degree in a relevant field and employed in universities/colleges, research agencies/institutes, hospitals, and other health related agencies who are members of the Regional Health Research and Development Consortia (RHRDC) are eligible to apply for the research grant.
How to submit
Interested lead proponents must submit their capsule proposals using the DOST-PCHRD forms. Research proposals submitted must be duly endorsed by the RHRDC concerned.
The RHRDC shall submit priority capsule proposal to:
The Executive Director
Philippine Council for Health Research and Development
Department of Science and Technology
Saliksik Building, DOST Compound, Gen. Santos Ave., Bicutan Taguig City 1631 Philippines
Successful proponents will be invited to join a write-shop for the development of the full proposal.
Deadline for submission of capsule proposals is on or before April 30, 2020
